Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [15018]

A novel, selective and potent inhibitor of the oncogenic protein BCL-XL

A novel, selective and potent inhibitor of the oncogenic protein BCL-XL

Space: the final frontier of cancer research

Space: the final frontier of cancer research

Researchers uncover 'fingerprint' of breast cancers that spread to the brain

Researchers uncover 'fingerprint' of breast cancers that spread to the brain

AACR 2013: AKT inhibitor AZD5363 well tolerated, yielded partial response in patients with advanced solid tumours

AACR 2013: AKT inhibitor AZD5363 well tolerated, yielded partial response in patients with advanced solid tumours

AACR 2013: Biomarker analysis identified women most likely to benefit from T-DM1

AACR 2013: Biomarker analysis identified women most likely to benefit from T-DM1

AACR 2013: Screening blood samples for cancer-driving mutations more comprehensive than analysing traditional tumour biopsy

AACR 2013: Screening blood samples for cancer-driving mutations more comprehensive than analysing traditional...

IMW 2013: The role of allotransplant in the era of novel therapies for multiple myeloma

IMW 2013: The role of allotransplant in the era of novel therapies for multiple myeloma

IMW 2013: Characterisation of minimal residual disease in an era of complete response in multiple myeloma

IMW 2013: Characterisation of minimal residual disease in an era of complete response in multiple myeloma

Protein that takes care of our DNA is critical to leukaemia

Protein that takes care of our DNA is critical to leukaemia

Third-generation device significantly improves capture of circulating tumour cells

Third-generation device significantly improves capture of circulating tumour cells

More from ecancer